Circassia Group (CIR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

25.00p
   
  • Change Today:
      0.60p
  • 52 Week High: 29.10
  • 52 Week Low: 12.93
  • Currency: UK Pounds
  • Shares Issued: 376.91m
  • Volume: 3,174
  • Market Cap: £94.23m
  • RiskGrade: 7

CIR Overview

Circassia is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CFO: Julien Cotta
Chairman: Francesco Granata
Chief Financial Officer and Senior Vice President: Michael R D Roller
Executive Chairman: Ian Johnson
Executive Director: Jonathan Emms
Independent Non-Executive Director: Lota S Zoth
Independent Non-Executive Director: Marvin S Samson
Non-Executive Chairman: Jo Le Couilliard
Senior Independent Non-Executive Director: Jean-Jacques Garaud
Senior Vice President: Rod Hafner
Non-Executive Dir: Sharon Curran, Garry Watts, Heribert Staudinger

Contact Details

Address: Northbrook House, Robert Robinson Avenue, The Oxford Science Park, Oxford, UK, OX4 4GA
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.circassia.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
Overseas Listings: BATSLON:CIRL
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CIR Market Data

Currency UK Pounds
Share Price 25.00p
Change Today 0.60p
% Change 2.46 %
52 Week High 29.10
52 Week Low 12.93
Volume 3,174
Shares Issued 376.91m
Market Cap £94.23m
RiskGrade 7

CIR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.13% above the market average4.13% above the market average4.13% above the market average4.13% above the market average4.13% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Price Trend
27.55% above the market average27.55% above the market average27.55% above the market average27.55% above the market average27.55% above the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Income Not Available
Growth
42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CIR Dividends

No dividends found

Trades for 08-Jul-2020

Time Volume / Share Price
12:02 3 @ 25.00p
11:42 2,680 @ 24.31p
11:40 28 @ 24.43p
11:15 26 @ 24.31p
10:46 9 @ 24.31p

CIR Key Personnel

Chair Francesco Granata
CFO Julien Cotta

Top of Page